After undergoing a double mastectomy in 2008, breast cancer survivor Christina Applegate has preventively had her ovaries and fallopian tubes removed.
NYS Entity Status
NYS Filing Date
SEPTEMBER 14, 2011
NYS DOS ID#
NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION
2011 - HANDS OF HOPE FOUNDATION FOR BREAST CANCER INC.
Around the Web
- Breast cancer survivor Christina Applegate reveals she recently had ovaries removed
Thursday Oct 12, 2017
- New Data Shows We’re Winning The Fight Against Breast Cancer
By Dan Seitz - Tuesday Oct 3, 2017
If new data is any proof, we're winning the fight against breast cancer.
- Woman says surgeons mistakenly removed her breasts and uterus
By Tamar Lapin - Wednesday Oct 25, 2017
An Oregon woman is suing surgeons who left her irreparably damaged when they unnecessarily removed her breasts and uterus, she said. Elisha Cooke-Moore, 36, had a recommended double mastectomy and hysterectomy after genetic test results showed she was at risk for breast and uterine cancer, she told the Washington Post. Months after the surgeries she...
- Fake Breast Cancer Charity Must Shut Down, Pay $350K To Real Charities
By Laura Northrup - Friday Jun 16, 2017
A purported charity called The Breast Cancer Survivors Foundation existed for six years, raising money through direct mailers and soliciting donors over the phone. It took in about $3 million per year, spinning heartwarming tales in its mailings of helping patients. This turned out to not actually be true, and those millions went to the professional fundraiser who ran the …
- Komen Awards $30.7 Million for Breast Cancer Research
By firstname.lastname@example.org (Matt Sinclair) - Tuesday Oct 3, 2017
The ninety-eight grants will support research related to new screening technologies, treatments for metastatic and aggressive types of breast cancer, and disparities in breast cancer outcomes....
- Power to the Patient: Meet Xconomy’s Patient Partnership Award Finalists
By Corie Lok - Monday Aug 28, 2017
It’s clear at this point that patients are no longer just subjects in clinical trials. Thanks to the growing power of patient advocacy groups—and an FDA eager to hear their perspective—patients and drug developers are increasingly finding creating ways to work together, as we’ve seen with the four finalists in the Patient Partnership category of […]